Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387157073> ?p ?o ?g. }
- W4387157073 abstract "Targeted eradication of transformed or otherwise dysregulated cells using monoclonal antibodies (mAb), antibody-drug conjugates (ADC), T cell engagers (TCE), or chimeric antigen receptor (CAR) cells is very effective for hematologic diseases. Unlike the breakthrough progress achieved for B cell malignancies, there is a pressing need to find suitable antigens for myeloid malignancies. CD123, the interleukin-3 (IL-3) receptor alpha-chain, is highly expressed in various hematological malignancies, including acute myeloid leukemia (AML). However, shared CD123 expression on healthy hematopoietic stem and progenitor cells (HSPCs) bears the risk for myelotoxicity. We demonstrate that epitope-engineered HSPCs were shielded from CD123-targeted immunotherapy but remained functional, while CD123-deficient HSPCs displayed a competitive disadvantage. Transplantation of genome-edited HSPCs could enable tumor-selective targeted immunotherapy while rebuilding a fully functional hematopoietic system. We envision that this approach is broadly applicable to other targets and cells, could render hitherto undruggable targets accessible to immunotherapy, and will allow continued posttransplant therapy, for instance, to treat minimal residual disease (MRD)." @default.
- W4387157073 created "2023-09-30" @default.
- W4387157073 creator A5000263633 @default.
- W4387157073 creator A5007644395 @default.
- W4387157073 creator A5010006480 @default.
- W4387157073 creator A5015044205 @default.
- W4387157073 creator A5016441319 @default.
- W4387157073 creator A5018820879 @default.
- W4387157073 creator A5025662384 @default.
- W4387157073 creator A5028209082 @default.
- W4387157073 creator A5028917405 @default.
- W4387157073 creator A5030664248 @default.
- W4387157073 creator A5033585559 @default.
- W4387157073 creator A5034460129 @default.
- W4387157073 creator A5045715769 @default.
- W4387157073 creator A5049569891 @default.
- W4387157073 creator A5049573758 @default.
- W4387157073 creator A5056979468 @default.
- W4387157073 creator A5057595671 @default.
- W4387157073 creator A5059867518 @default.
- W4387157073 creator A5060735079 @default.
- W4387157073 creator A5062828125 @default.
- W4387157073 creator A5067028992 @default.
- W4387157073 creator A5073502390 @default.
- W4387157073 creator A5075692405 @default.
- W4387157073 creator A5075940909 @default.
- W4387157073 creator A5077066907 @default.
- W4387157073 creator A5078300495 @default.
- W4387157073 creator A5085244381 @default.
- W4387157073 creator A5086886315 @default.
- W4387157073 creator A5088274469 @default.
- W4387157073 creator A5088431517 @default.
- W4387157073 creator A5089375913 @default.
- W4387157073 creator A5090352024 @default.
- W4387157073 creator A5090435126 @default.
- W4387157073 creator A5092450655 @default.
- W4387157073 date "2023-09-29" @default.
- W4387157073 modified "2023-10-18" @default.
- W4387157073 title "Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy" @default.
- W4387157073 cites W1966542058 @default.
- W4387157073 cites W2004360551 @default.
- W4387157073 cites W2011136801 @default.
- W4387157073 cites W2013971016 @default.
- W4387157073 cites W2017737576 @default.
- W4387157073 cites W2022197596 @default.
- W4387157073 cites W2050623157 @default.
- W4387157073 cites W2051549641 @default.
- W4387157073 cites W2061635000 @default.
- W4387157073 cites W2061687202 @default.
- W4387157073 cites W2070387456 @default.
- W4387157073 cites W2075959895 @default.
- W4387157073 cites W2096420946 @default.
- W4387157073 cites W2102461176 @default.
- W4387157073 cites W2115603949 @default.
- W4387157073 cites W2118796952 @default.
- W4387157073 cites W2129702476 @default.
- W4387157073 cites W2130011407 @default.
- W4387157073 cites W2137566700 @default.
- W4387157073 cites W2146891463 @default.
- W4387157073 cites W2161045200 @default.
- W4387157073 cites W2162067157 @default.
- W4387157073 cites W2167550136 @default.
- W4387157073 cites W2245592118 @default.
- W4387157073 cites W2253581743 @default.
- W4387157073 cites W2279093595 @default.
- W4387157073 cites W2409512187 @default.
- W4387157073 cites W2530531760 @default.
- W4387157073 cites W2530601336 @default.
- W4387157073 cites W2547418311 @default.
- W4387157073 cites W2589417329 @default.
- W4387157073 cites W2761903029 @default.
- W4387157073 cites W2785402389 @default.
- W4387157073 cites W2787698730 @default.
- W4387157073 cites W2791294122 @default.
- W4387157073 cites W2792588868 @default.
- W4387157073 cites W2800912743 @default.
- W4387157073 cites W2804523481 @default.
- W4387157073 cites W2805058565 @default.
- W4387157073 cites W2811405063 @default.
- W4387157073 cites W2818540548 @default.
- W4387157073 cites W2888063816 @default.
- W4387157073 cites W2894996603 @default.
- W4387157073 cites W2900885456 @default.
- W4387157073 cites W2912557946 @default.
- W4387157073 cites W2914985409 @default.
- W4387157073 cites W2915459742 @default.
- W4387157073 cites W2947751606 @default.
- W4387157073 cites W2953623020 @default.
- W4387157073 cites W2954506039 @default.
- W4387157073 cites W2973021197 @default.
- W4387157073 cites W2992036306 @default.
- W4387157073 cites W2992738455 @default.
- W4387157073 cites W3017040524 @default.
- W4387157073 cites W3022057969 @default.
- W4387157073 cites W3034816469 @default.
- W4387157073 cites W3035764705 @default.
- W4387157073 cites W3117337730 @default.
- W4387157073 cites W3133204065 @default.
- W4387157073 cites W3171358427 @default.
- W4387157073 cites W3175561872 @default.